Wang Z, Figueiredo-Pereira C, Oudot C, Vieira H L A, Brenner C
INSERM UMR-S 1180-LabEx LERMIT, Université Paris-Sud, Université Paris-Saclay, Châtenay Malabry, France.
CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal.
Int Rev Cell Mol Biol. 2017;331:245-287. doi: 10.1016/bs.ircmb.2016.09.010. Epub 2017 Jan 2.
Mitochondria are deeply involved in cell fate decisions via their multiple roles in metabolism, cell growth, and cell death. In healthy cells, these functions are highly regulated to provide sufficient energy for cell function, maintain cell homeostasis, and avoid undesirable cell death. This is achieved by an orchestrated cooperation of cellular and molecular mechanisms such as mitochondrial mass control (mitophagy vs biogenesis), oxidative phosphorylation, redox and calcium homeostasis, and the balance between pro- and antiapoptotic proteins. In the 1990s, mitochondria have been demonstrated to directly control some forms of regulated cell death as well indirectly through energetic metabolism modulation. However, a large body of literature revealed that distinct cell death modalities can coexist in vivo as well as that mitochondria can be dispensable for certain forms of cell death. Likewise, unexpected interconnections between cell death pathways can lead to an amplification of lethality, as well as a defeat of cell death resistance mechanisms. This revealed a complexity of the control of cell fate and a crucial need to reevaluate the role of mitochondria. Here, we will review the various cell death pathways such as apoptosis and mitochondrial permeability transition-driven necrosis and discuss how mitochondrial proteins and mitophagy regulate them. Finally, the role of mitochondrial proteins in the triggering of cell death and mitophagy in pathological models, such as cardiac and brain pathologies, will be highlighted. This may help to define efficient cytoprotective therapeutic strategies based on the targeting of mitochondria.
线粒体通过在代谢、细胞生长和细胞死亡中的多种作用,深度参与细胞命运的决定。在健康细胞中,这些功能受到高度调控,以提供足够的能量用于细胞功能、维持细胞内稳态并避免不必要的细胞死亡。这是通过细胞和分子机制的协同合作实现的,如线粒体质量控制(线粒体自噬与生物发生)、氧化磷酸化、氧化还原和钙稳态,以及促凋亡蛋白和抗凋亡蛋白之间的平衡。在20世纪90年代,线粒体已被证明既能直接控制某些形式的程序性细胞死亡,也能通过能量代谢调节间接控制。然而,大量文献表明,不同的细胞死亡方式可在体内共存,而且线粒体对于某些形式的细胞死亡可能是不必要的。同样,细胞死亡途径之间意想不到的相互联系可导致致死性的放大,以及细胞死亡抵抗机制的失效。这揭示了细胞命运控制的复杂性,以及重新评估线粒体作用的迫切需求。在这里,我们将综述各种细胞死亡途径,如凋亡和线粒体通透性转换驱动的坏死,并讨论线粒体蛋白和线粒体自噬如何调节它们。最后,将强调线粒体蛋白在病理模型(如心脏和脑部疾病)中触发细胞死亡和线粒体自噬的作用。这可能有助于基于线粒体靶向确定有效的细胞保护治疗策略。